Pedersen, Eva S L; Spycher, Ben D; de Jong, Carmen; Halbeisen, Florian; Ramette, Alban; Gaillard, Erol A; Granell, Raquel; Henderson, A John; Kuehni, Claudia E (2019). The simple 10-item PARC tool to predict childhood asthma - an external validation. The Journal of allergy and clinical immunology, 7(3), 943-953.e4. Elsevier 10.1016/j.jaip.2018.09.032
|
Text
Pedersen JAllergyClinImmunolPract 2018_manuscript.pdf - Accepted Version Available under License Creative Commons: Attribution-Noncommercial-No Derivative Works (CC-BY-NC-ND). Download (523kB) | Preview |
|
![[img]](https://boris.unibe.ch/style/images/fileicons/text.png) |
Text
Pedersen_JAllergyClinImmunolPract_2019.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (682kB) |
BACKGROUND
External validation of prediction models is important to assess generalisability to other populations than the one used for model development. The Predicting Asthma Risk in Children (PARC) tool, developed in the Leicestershire Respiratory Cohort (LRC), uses information on preschool respiratory symptoms to predict asthma at school age.
OBJECTIVE
We performed an external validation of PARC using the Avon Longitudinal Study of Parents and Children (ALSPAC).
METHODS
We defined inclusion criteria, prediction score items at baseline and asthma at follow-up in ALSPAC to match those used in LRC using information from parent-reported questionnaires. We assessed performance of PARC by calculating sensitivity, specificity, predictive values, likelihood ratios, area under the curve (AUC), Brier score and Nagelkerke's R-squared. Sensitivity analyses varied inclusion criteria, scoring items and outcomes.
RESULTS
The validation population included 2690 children with preschool respiratory symptoms of which 373 (14%) had asthma at school age. Discriminative performance of PARC was similar in ALSPAC (AUC=0.77, Brier score 0.13) as in LRC (0.78, 0.22). The score cut-off of 4 showed the highest sum of sensitivity (69%) and specificity (76%) and positive and negative likelihood ratios of 2.87 and 0.41, respectively. Changes to inclusion criteria, scoring items or outcome definitions barely altered the prediction performance.
CONCLUSION
Performing equally well in the validation cohort as in the development cohort, PARC is a valid tool for predicting asthma in population based cohorts. Its use in clinical practice is ready to be tested.
Actions (login required)
 |
Edit item |